- SEK1.29bn
- SEK1.20bn
- SEK128.95m
Brief: Genovis Q1 net sales up at SEK 4.8 million
Brief: Genovis carries out directed share issue with proceeds of SEK 11.5 mln
Brief: Genovis Q3 operating loss narrows to SEK 1.1 mln
Brief: Genovis signs a license agreement with Life Technologies Corporation
Brief: Genovis Q2 operating loss widens to SEK 8.0 mln
Brief: Genovis rights issue oversubscribed
Brief: Genovis elects Mårten Winge as Chairman
Brief: Genovis Q1 operating loss narrows to SEK 3.4 million
Brief: Genovis decides on new share issue at SEK 1.25/shr
Brief: Genovis signs strategic cooperation agreement with Alphalyse A/S
Brief: Genovis Q4 EBITDA loss narrows to 3.9 million Swedish crowns
Brief: Genovis launches new enzyme product
Brief: Genovis Q3 revenue up 105 pct at SEK 3.4 million
Brief: Genovis reorganizes and closes down GeccoDots
Brief: Genovis Q2 EBITDA loss slightly widens to SEK 4.9 million
Brief: Genovis says rights issue oversubscribed by 63 pct
Brief: Genovis new share issue oversubscribed by 63 pct
Brief: Genovis proposes Sarah Fredriksson new chairman; names Fredrik Olsson CEO
Brief: Genovis Q1 operating loss widening to SEK 5.0 million